Erasca, Inc.

New phase 1_2 trial NCT04866134 posted by Erasca, Inc.: "A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors". New trial on a phase 1_2 active not recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 78 days ago.

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.

New phase 1 trial NCT07021898 posted by Erasca, Inc.: "A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.". New trial on a phase 1 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 279 days ago.

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.